Kinnevik

Tatiana Shalalvand, Investment Director at Kinnevik, and Staffan Helgesson, founder of Creandum, were guests on the latest episode of Dagens industri’s podcast and TV show “Mitt i bruset”. This specific episode aims to inspire entrepreneurs to take the leap and start a business. With Dagens industri’s Ida Hansson Brusewitz, Staffan and Tatiana discussed what they look for when backing founders and how to handle uncertainty as you scale your business. Tatiana and Staffan also delved into their respective investments in Aira and Spotify and shared their thoughts on which sectors will dominate the investment scene going forward. Watch the episode here (in Swedish): https://lnkd.in/dkf6xSAK

We are thrilled to welcome Amanda Hillström, our new CEO Trainee – LUMA #39, to the Kinnevik team! Get to know Amanda and her journey to Kinnevik here: https://lnkd.in/da4hy44e

Meet Anders Strandberg, Legal Director at Kinnevik. Working with everything related to the legal field, Anders supports our portfolio companies in all sorts of matters throughout their growth journeys. Discover what the role of a Legal Director entails and get his best advice for founders on what to look for in an investor. 

Meet Carl Arfwidson, a member of the Strategy & Finance team at Kinnevik. With a portfolio now consisting of 95% unlisted assets, financial analysis has become more crucial than ever. Read what Carl has to say about the importance of financial analysis, the advantages of being a listed investment company, and what he enjoys most about working at Kinnevik.

Kinnevik’s Maria-Helen Maras joined a panel at this week’s HLTH Europe to discuss European healthcare startups scaling in the US.    The discussion covered navigating regulation and reimbursement models, the importance of channel partnerships, getting the critical first hires correct, and practical dos and don’ts. A topic more relevant than ever, as the American market becomes increasingly important for European startups.   Thanks for having us and for the great discussions #HLTHEurope 

At last week’s Annual General Meeting, our Chairman, James Anderson, highlighted Kinnevik’s strategy and focus going forward – efforts aligned with our vision of being Europe’s leading listed growth investor. A vision being realised by backing companies that are redefining their industries, specifically within our focus sectors: Health & Bio, Software, Climate Tech, and Platforms & Marketplaces.

Why should climate tech be a prioritized sector for investments? And how can purpose and profitability be a given combination rather than a contradiction? Meet Anna Adlarson, Venture & Growth investor at Kinnevik, and discover her views on investing in climate tech.  

At our Annual General Meeting this Monday, we had the honor of welcoming two new additions to the Kinnevik board – Maria Redin and Claes Glassell. With their valuable experience and unique knowledge, Maria and Claes are appreciated additions to the board. We look forward to their contributions to Kinnevik and to the continued growth and development of our companies. Warm welcome!

The landscape of drug discovery is transforming with AI and with big tech giants addressing key challenges in data, compute power, and algorithm advancements. At Kinnevik, we're proud to back leaders like Recursion and Enveda Biosciences, companies now partnering with NVIDIA and Microsoft, respectively, to further drive this revolution.   Read more in this article by Ala Alenazi, Venture and Growth Investor at Kinnevik, and discover how these partnerships are shaping the future of healthcare. Link to article: https://lnkd.in/d7Bf9ugn

Yesterday, Kinnevik held its Annual General Meeting, concluding milestones and setting directions ahead.   2023 was undeniably a challenging year for our portfolio companies, employees, and shareholders. Fortunately, 2024 has started on a brighter note, and we are well-positioned to continue our transformation as Europe’s leading listed growth investor.   Back in 2018, our goal was to build a portfolio of new, promising companies. Since then, we have invested 27 BSEK in over 30 companies, crafting a balanced portfolio across different maturity phases in our four key sectors: Health & Bio, Software, Climate Tech, and Platforms & Marketplaces. Over the last 6 years, we have also released a total value of 88 BSEK to shareholders in shares and cash, including the extraordinary divided approved by the AGM.    In February, we announced the divestment of Tele2. A company whose strong value creation has been instrumental in building the Kinnevik of today, and this divestment will be equally important for our future. This was the final step in our strategic transformation to becoming a pure growth investor, a transition that is now complete upon closing of the transaction.   I want to give my thanks to everyone who attended the meeting yesterday. On October 23, we will host a Capital Markets Day in Stockholm, where we will dive deeper into the future of Kinnevik, alongside many of our portfolio companies who will be there to provide insights into their businesses. I look forward to meeting many of you there.